{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Response is defined as platelet increases to greater than 50 x 10\\^9/L for more than 2 weeks.","groups":[{"description":"Patients receive romiplostim SC once weekly for up to 6 weeks. Patients achieving a platelet count \\> 50 x 10\\^9 then receive romiplostim once weekly during 1 course of chemotherapy and may continue for as long as benefit is seen..\n\nromiplostim: Given SC","id":"OG000","title":"Supportive Care (Romiplostim)"}],"populationDescription":"Data was not analyzed. Dr. Mazumder left institution and data was not analyzed.","reportingStatus":"POSTED","timeFrame":"8 weeks","title":"Percentage of Patients Who Have Responded","type":"PRIMARY"}